Capecitabine and Oxaliplatin (XELOX) for the Treatment of Patients with Metastatic Gastric Cancer and Severe Liver Dysfunction

Gastric cancer patients with severe liver dysfunction secondary to hepatic metastases have limited treatment options. Most cytotoxic drugs have a narrow therapeutic index. Although both capecitabine and oxaliplatin have been well tolerated as single agents for patients with severe hepatic dysfunctio...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Hwang, Seung Jae, Park, Jong Won, Lee, Sehe Dong, Kim, Gyong Jung, Sin, Cheol Ho, Nam, Seung-Hyun, Kim, Bong-Seog
Format: Artigo
Jezik:Inglês
Izdano: The Korean Association of Internal Medicine 2006
Teme:
Case Report
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3891032/
https://ncbi.nlm.nih.gov/pubmed/17249509
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3904/kjim.2006.21.4.252
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items